LOCALLY ADVANCED CHOLANGIOCARCINOMA
Clinical trials for LOCALLY ADVANCED CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a pill target Hard-to-Treat bile duct cancers? a new drug puts FGFR2 mutations to the test
Disease control OngoingThis early-stage trial is testing an experimental oral drug, TYRA-200, in people with advanced bile duct cancer (intrahepatic cholangiocarcinoma) and other solid tumors that have specific changes in the FGFR2 gene. The study aims to find a safe and effective dose and to see wheth…
Matched conditions: LOCALLY ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug targets bile duct cancer in small trial
Disease control OngoingThis phase II trial tests a drug called sacituzumab govitecan in 15 people with advanced bile duct cancer that has spread or returned after treatment. The drug works like a smart bomb, attaching to a protein on cancer cells and delivering a toxic payload to kill them. Researchers…
Matched conditions: LOCALLY ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC